Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
Clinical Outcomes Following Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy in the United States: The Endure Study | Synapse
March 3, 2026
Clinical Outcomes Following Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy in the United States: The Endure Study
MS
Michelle Long Schoettler
Emory University
AM
Andrew Messali
University of Southern California
QA
Qiana Amos
Optum (United States)
Ver todo
Puntos clave
Clinical outcomes show a significant association with thrombotic microangiopathy, affecting recovery.
The analysis identified 45% of patients experienced vascular complications during the follow-up phase.
This observational analysis utilized a comprehensive dataset from multiple transplant centers across the U.S.
The findings highlight the need for further investigation to optimize management in hematopoietic stem cell transplant recipients.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Schoettler et al. (Sun,) studied this question.
synapsesocial.com/papers/69a760cec6e9836116a2de54
https://doi.org/https://doi.org/10.1016/j.jtct.2025.12.672